pSivida sells subsidiary for $3.6m

PERTH-HEADQUARTERED bio-nanotech company, pSivida Ltd, has sold its subsidiary AION Diagnostics Inc to US-based private equity group GEM Global Yield Fund for around $3.6 million, following the company’s planned float on the Frankfurt Stock Exchange.